This inventor holds 2 USPTO granted patents. Top assignee: The Cleveland Clinic Foundation. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Innovations of Warren D Heston
Introduction
Warren D Heston is a notable inventor based in Cleveland, OH. He has made significant contributions to the field of medical imaging, particularly in the development of imaging agents for prostate cancer treatment. With a total of 2 patents, Heston's work is recognized for its potential impact on patient care.
Latest Patents
Heston's latest patents focus on PSMA-targeting imaging agents. These agents are designed to specifically target PSMA, a protein commonly found in prostate cancer cells. The patents describe a PSMA-specific imaging agent comprising a compound that includes an organic spacer group with a carbon chain length ranging from 5 to 30. The agent also incorporates an amino acid that forms part of a negatively charged peptide oligomer. This innovative approach allows for the imaging of PSMA within tissue regions, which can guide the treatment of diseases such as prostate cancer.
Career Highlights
Warren D Heston is affiliated with the Cleveland Clinic Foundation, where he continues to advance research in medical imaging. His work is characterized by a commitment to improving diagnostic techniques and treatment options for patients suffering from prostate cancer.
Collaborations
Heston collaborates with esteemed colleagues, including Steve Shih-Lin Huang and Xinning Wang. These partnerships enhance the research and development of innovative imaging solutions.
Conclusion
Warren D Heston's contributions to the field of medical imaging, particularly through his PSMA-targeting imaging agents, demonstrate his dedication to advancing healthcare technology. His work has the potential to significantly improve the diagnosis and treatment of prostate cancer, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
